CurrentEndo
Get Weekly

Topic · page 7 of 35

Osteoporosis, bone & mineral

Osteoporosis in women and men, fracture risk and bone density, fragility fractures and their secondary prevention, bone drugs and treatment sequence; hyperparathyroidism and hypoparathyroidism, vitamin D, calcium and phosphate disorders, rare metabolic bone disease

Briefs 241–280 of 1,367 placed here, newest publication first

Briefs in Osteoporosis, bone & mineral

Newest publication first

  1. Lancet Diabetes Endocrinol

    3 months vs 12 months of romosozumab for postmenopausal osteoporosis (LIDA): an open-label, non-inferiority, randomised controlled trial

    Randomized controlled trial

  2. Osteoporos Int

    Fracture risks in patients with arginine vasopressin deficiency: a nationwide matched cohort study

    Cohort study

  3. J Bone Miner Res

    Fracture probability is predictive of fall-associated hospitalization: the Manitoba BMD Registry

    Cohort study

  4. J Bone Miner Res

    The effects of marine fatty acid omega-3 supplements on incident fractures and bone mineral density in generally healthy adults

    Randomized controlled trial

  5. Osteoporos Int

    Effects of teriparatide on hip structure and bone microarchitecture in women with anorexia nervosa: a placebo-controlled randomized trial

    Randomized controlled trial

  6. Osteoporos Int

    Bisphosphonate treatment for secondary osteoporosis in children, youth, and young adults: a systematic review and meta-analysis

    Meta-analysis

  7. Osteoporos Int

    Paternal age is associated with offspring bone health—but not soft tissue composition or fracture: the Vitamin D in Pregnancy Study

    Cohort study

  8. Osteoporos Int

    Incidence of first and subsequent fractures in multiple myeloma patients: a parallel cohort study using UK CPRD dataset

    Cohort study

  9. Osteoporos Int

    Prevalence and relative risk of fractures and osteoporosis in patients with ankylosing spondylitis: a systematic review and meta-analysis

    Meta-analysis

  10. J Bone Miner Res

    Decreased nonvertebral fracture incidence with zoledronate use for >3 years: post hoc analysis of a Randomized Controlled Trial

    Secondary analysis

  11. Osteoporos Int

    Clinical and economic impact of deep learning-enhanced opportunistic osteoporosis screening using chest radiographs with and without the osteoporosis self-assessment tool for Asians (OSTA)

    Research article

  12. Pituitary

    Long-term effect on bone mineral density of denosumab in the treatment of hyperpituitarism driven osteoporosis: an exploratory study

    Cohort study

  13. J Bone Miner Res

    QCT-based geometric, densitometric, and biomechanical properties of the aging human thoracolumbar spine

    Cross-sectional study

  14. Osteoporos Int

    Conservative treatments for non-surgically managed osteoporotic vertebral compression fractures: a network meta-analysis of long-term pain and quality of life

    Meta-analysis

  15. Osteoporos Int

    Post-fracture care and predictors of anti-osteoporotic treatment in Switzerland: a nationwide health claims analysis

    Cohort study

  16. Osteoporos Int

    Muscle mass, not fat mass, predicts vertebral fracture risk: Vietnam osteoporosis study

    Cross-sectional study

  17. J Bone Miner Res

    Diagnosis, treatment, and management recommendations for cleidocranial dysplasia: A modified Delphi panel

    Guideline or statement

  18. J Clin Endocrinol Metab

    Pharmacological interventions to improve bone density in functional hypothalamic amenorrhea: a systematic review and network meta-analysis of randomized clinical trials

    Meta-analysis

  19. Diabetes Metab

    Fracture risk and treatment thresholds in patients with diabetes

    Case-control study

  20. J Bone Miner Res

    Safety of low dose inpatient zoledronic acid in acute hip fracture patients with advanced chronic kidney disease

    Cohort study

  21. Osteoporos Int

    Controlling Nutritional Status (CONUT) score as a key predictor of disability following conservative treatment of osteoporotic vertebral fractures

    Case-control study

  22. J Bone Miner Res

    External validation of a novel HR-pQCT based fracture risk assessment tool (μFRAC) in a male cohort: the osteoporotic fractures in men (MrOS) study

    Diagnostic or prognostic study

  23. Osteoporos Int

    Radiofrequency Echographic Multi Spectrometry (REMS) for the evaluation of bone health in systemic lupus erythematosus (SLE)

    Diagnostic or prognostic study

  24. Eur J Endocrinol

    Continuous subcutaneous administration of teriparatide as a therapeutic option in chronic hypoparathyroidism: retrospective study in three tertiary care centers of the epi-hypo study

    Cohort study

  25. J Clin Endocrinol Metab

    Impact of Parathyroidectomy on Vascular Stiffness: Exploring Pulse Wave Velocity and Renal Resistive Index

    Cohort study

  26. Osteoporos Int

    A programmatic approach to osteoporosis treatment: insight from a 20-year longitudinal study

    Cohort study

  27. Endocr Pract

    Postparathyroidectomy Bone Density Changes in Patients With Biochemically Mild Primary Hyperparathyroidism

    Cohort study

  28. J Bone Miner Res

    Associations of muscle strength and functional power with longitudinal change in HR-pQCT bone parameters: the Osteoporotic Fractures in Men (MrOS) Study

    Cohort study

  29. J Bone Miner Res

    Spine age derived from DXA vertebral fracture assessment images predicts incident fractures and mortality: the Manitoba Bone Mineral Density Registry

    Cohort study

  30. Endocr Pract

    Primary Hyperparathyroidism Associated With Elevated Coronary Artery Calcium Scores and Increased Cardiovascular Risk

    Cohort study

  31. Osteoporos Int

    Burden of accumulating fragility fractures on health service usage and costs among post-menopausal women

    Cohort study

  32. Osteoporos Int

    Romosozumab mitigates progression from radiological to symptomatic adjacent-level fractures compared to teriparatide

    Cohort study

  33. J Clin Endocrinol Metab

    Anti-Mullerian Hormone and Collagen Type I C-telopeptide Predict Fast, Imminent Bone Loss in Early Perimenopause: SWAN

    Cohort study

  34. Osteoporos Int

    Bone density and remodeling after discontinuation of sequential therapy for premenopausal idiopathic osteoporosis

    Cohort study

  35. Osteoporos Int

    Changes in treatment eligibility with race-neutral US FRAX would be modest: estimates using the National Health and Nutrition Examination Survey (NHANES)

    Cross-sectional study

  36. J Clin Endocrinol Metab

    Longitudinal Changes in Sex Hormones in a Population of Older Community-dwelling Men

    Cohort study

  37. Osteoporos Int

    Associations between dietary index for gut microbiota and bone health outcomes

    Cross-sectional study

  38. Osteoporos Int

    Comparative effects of lumbar spine bone area from DXA on trabecular bone score and bone mineral density: the Manitoba BMD Registry

    Cohort study

  39. J Bone Miner Res

    A randomized Phase 1b trial evaluating the pharmacodynamics of ilofotase alfa in adults with hypophosphatasia

    Randomized controlled trial

  40. Osteoporos Int

    Fracture incidence and osteoporosis treatment in Parkinson’s disease: a population-based cohort study

    Cohort study

All 1,367 Briefs in ExploreShowing Briefs 241–280 of 1,367, newest first